Evidence-based metabolic restoration integrating GLP-1/GIP peptide therapy, biological assessment, and personalized protocols for sustainable weight and metabolic outcomes.

At BioReset, weight management is never treated as a cosmetic issue or a simple matter of willpower. Excess adiposity is a biological state — one driven by hormonal signaling, metabolic dysfunction, inflammation, mitochondrial compromise, microbiome imbalance, and often chronic stress or toxic burden.
Our medical weight control programs begin with a comprehensive biological assessment, then integrate targeted interventions that restore metabolic function at its source. Where appropriate, we incorporate advanced peptide therapies including Tirzepatide — a dual GLP-1/GIP agonist — as part of a broader integrative protocol.
Comprehensive laboratory profiling: insulin, glucose tolerance, HbA1c, thyroid panel, cortisol rhythm, inflammatory markers, and lipid metabolism.
Assessing gut-derived metabolic signals, LPS translocation, and microbial influences on appetite regulation and fat storage.
Evaluating environmental obesogens and endocrine disruptors that interfere with metabolic signaling and adipocyte function.
Where clinically indicated, Tirzepatide and other GLP-1/GIP-based therapies are integrated within a personalized biological protocol.
Nutritional guidance, movement prescription, sleep optimization, and stress management tailored to the individual metabolic profile.
Tirzepatide is a novel dual incretin agonist that activates both GLP-1 and GIP receptors. Unlike earlier single-pathway agents, this dual action addresses multiple metabolic dysregulations simultaneously: appetite suppression, glucose regulation, fat oxidation, and pancreatic beta-cell preservation.
At BioReset, Tirzepatide is not prescribed as a standalone solution. It is integrated into a comprehensive biological program that addresses the root causes of metabolic dysfunction — ensuring that weight loss is not merely induced, but sustained through restored biological function.
All peptide therapies are prescribed under direct medical supervision, with ongoing monitoring of metabolic markers, body composition, and patient response.
Real patient experiences from integrative medical weight control at BioReset. Outcomes reflect biological metabolic function restoration, not restriction.
“After years of yo-yo dieting, BioReset's metabolic assessment revealed insulin resistance and thyroid dysfunction no one had checked. The integrated protocol — not just peptide therapy — gave me sustainable results.”
I.M., 48
Metabolic Restoration Protocol — 5 months
“Tirzepatide at BioReset was not a quick fix — it was part of a biological program that addressed my gut health, mitochondrial function, and hormonal balance. I lost 18kg and kept it off for over a year.”
O.P., 55
Tirzepatide + Biological Protocol — 8 months
“PCOS had made weight loss impossible for me. The comprehensive hormonal, metabolic, and microbiome assessment finally explained why. Targeted treatment worked where every diet had failed.”
Q.L., 32
PCOS Metabolic Protocol — 6 months
“After years of yo-yo dieting, BioReset's metabolic assessment revealed insulin resistance and thyroid dysfunction no one had checked. The integrated protocol — not just peptide therapy — gave me sustainable results.”
I.M., 48
Metabolic Restoration Protocol — 5 months
Medical weight control at BioReset is not about restriction — it is about understanding why your biology resists weight loss, and designing a protocol that restores metabolic function from the inside out.